1994
DOI: 10.1128/mcb.14.3.2048
|View full text |Cite
|
Sign up to set email alerts
|

A single element of the elastase I enhancer is sufficient to direct transcription selectively to the pancreas and gut.

Abstract: The elastase I (El) gene is expressed at high levels in the exocrine pancreas and at lower levels in other regions of the gut. The transcriptional enhancer of the EI gene, from nucleotides -205 to -72, recapitulates the expression of the endogenous gene in transgenic mice; it directs not only pancreatic acinar cell expression of a human growth hormone (hGH) transgene but also expression to the stomach, duodenum, and colon. This pattern of selective expression limited to the gastroenteropancreatic organ system … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
56
0

Year Published

1996
1996
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(59 citation statements)
references
References 39 publications
3
56
0
Order By: Relevance
“…The trimeric Pancreas Transcription Factor 1 complex (PTF1) was first identified as an acinar enzyme gene activator (Rose et al, 1994;Krapp et al, 1996) and comprises a tissuespecific bHLH protein, Ptf1a; an ubiquitous bHLH protein, E2A or HEB (formerly known as p75, which provides a constitutive nuclear import function for the PTF1 protein complex) (Rose et al, 1994, Krapp et al, 1996, Sommer et al, 1991; and the distinct mammalian Suppressor of Hairless (RBP-J) protein, or the RBP-JL paralog (Obata et al, 2001;Beres et al, 2006). Ptf1a is expressed as early as E9.5 in most cells of the nascent pancreatic buds, and is essential for pancreas organogenesis in mouse and human (Kawaguchi et al, 2002;Krapp et al, 1998;Sellick et al, 2004).…”
Section: Ptf1amentioning
confidence: 99%
“…The trimeric Pancreas Transcription Factor 1 complex (PTF1) was first identified as an acinar enzyme gene activator (Rose et al, 1994;Krapp et al, 1996) and comprises a tissuespecific bHLH protein, Ptf1a; an ubiquitous bHLH protein, E2A or HEB (formerly known as p75, which provides a constitutive nuclear import function for the PTF1 protein complex) (Rose et al, 1994, Krapp et al, 1996, Sommer et al, 1991; and the distinct mammalian Suppressor of Hairless (RBP-J) protein, or the RBP-JL paralog (Obata et al, 2001;Beres et al, 2006). Ptf1a is expressed as early as E9.5 in most cells of the nascent pancreatic buds, and is essential for pancreas organogenesis in mouse and human (Kawaguchi et al, 2002;Krapp et al, 1998;Sellick et al, 2004).…”
Section: Ptf1amentioning
confidence: 99%
“…While it was discovered as an activator of acinar cell-specific genes [39], at this stage it helps define exocrine, endocrine, and ductal cell types within the pancreas by binding to and activating the PDX1 promoter [40]. Shortly after the specification of the pancreatic buds, further differentiation into pancreatic endoderm (PE) and subsequent endocrine cells is initiated by the expression of NK2 homeobox 2 (NKX2.2) [41] and NK6 homeobox 1 (NKX6.1) [42].…”
Section: Primary Transitionmentioning
confidence: 99%
“…In animals, the specificity of the enhancer is the sum of that of the A and B elements, whereas its overall strength includes synergy between all three elements. In transfected pancreatic acinar tumor cells in culture, the elements play similar roles except that each element is essential, whereas in acinar tissue in situ the B and C elements are largely redundant (15,16).…”
mentioning
confidence: 99%
“…In animals, the specificity of the enhancer is the sum of that of the A and B elements, whereas its overall strength includes synergy between all three elements. In transfected pancreatic acinar tumor cells in culture, the elements play similar roles except that each element is essential, whereas in acinar tissue in situ the B and C elements are largely redundant (15,16).Another strategy to probe the functional organization of complex enhancers is to substitute endogenous elements with an ectopic one to examine whether the enhancer complex is sufficiently flexible to integrate the function of the new element. In this report we describe the use of this strategy to test whether the tetracycline regulatory element, tetO, and its binding transactivator (tTA) (18) can integrate into the nucleoprotein complex of the EI enhancer to complement the transcriptional activities of the endogenous elements.…”
mentioning
confidence: 99%
See 1 more Smart Citation